Malignant Kidney Neoplasm — Trials

Malignant Kidney Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,142 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 453
Recruiting: 233
Ph III recruiting: 18
Growth YoY: +3.1%
Industry share: 29%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 38.2%
Trials / 1,000 deaths: 30.7 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (339)

clinicaltrialsPublishedShowing 101–150 of 555 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06582017	Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma	recruiting	Phase 1	100	Nammi Therapeutics IncINDUSTRY	1	Aug 27, 2026	clinicaltrials
NCT02402244	Project: Every Child for Younger Patients With Cancer	recruiting	—	75,000	Children's Oncology GroupNETWORK	6	Aug 25, 2026	clinicaltrials